Is Drug Price Transparency DOA?
Once again drug price transparency is in the news. Now it appears that efforts to improve pricing visibility are dead on arrival. If we look at recent actions by Pfizer and Mylan, it may well be. At...
View ArticleA Cloudy Future for the Sunshine Act
The due date for posting another year’s worth of Physician Payment Sunshine Act (a.k.a. Open Payments) data is fast approaching. But the future for the Sunshine Act is cloudy. A new Republican...
View ArticleSaving Independence -“Compliance” vs “Integrity” Officer
It happens every few years. The top compliance job gets a new title. Just in the past 25 years in life sciences, I have seen four major changes. First, there was Compliance Coordinator (my original...
View ArticleLife Science Compliance Update – July Issue
This is Not Your Parent’s Compliance Program – The New Era of Compliance Resourcing at Small to Mid-Size Pharmaceutical Companies Patrik Florencio, Esq., Steven Franchetti, Seth Whitelaw, J.D., LL.M.,...
View ArticleOne Purpose to Rule Them All – A Resounding “Yes “According to the District...
The breadth of liability under the False Claims Act including Anti-Kickback Statute is a closely watched area. Recently, the U.S District Court for the Eastern District of Missouri concluded that...
View ArticleA Bright Future or Unfulfilled Promise – An Update on Biosimilars and Their...
Biosimilars have a bright future and promise potentially significant health care cost savings, provided the regulatory, legal and commercial hurdles are removed. Recent activity by CVS and United...
View ArticleMISSING THE MARKET: GOVERNMENT STANDARDS ARE UNDERMINING COMPLIANCE EFFORTS...
First introduced into life sciences more than two decades ago as the result of a government settlement, compliance officers and compliance departments are now considered essential for pharmaceutical...
View ArticleUnitedHealth pushes back in whistleblower case
Check out my commentary in Saturday’s (April 14th) Business Section of the Minneapolis Star Tribune. The post UnitedHealth pushes back in whistleblower case appeared first on Whitelaw Compliance Group,...
View ArticleHave Your Cake & Write a Script Too
Stepping out of her car, Sally Pharmrep glanced again at her watch. If she was late, it would not be well received. Reaching into the back seat of her white, four-door Camry, she pulled out the large...
View ArticleWhitelaw Compliance Group to Attend West Chester University & Grow PA...
On Thursday, September 27, 2018, Whitelaw Compliance Group will be attending the open discussion hosted by West Chester University and Grow PA. The discussion will focus on how to provide students...
View ArticleDrug Pricing—The Next Compliance Waterloo
My latest article co-authored with Nicodemo Fiorentino and Jennifer O’Leary is available as a free download from the Mitchell Hamline Law Review. The current drug pricing war pits the...
View ArticleOpen Payments 2.0 – Big Changes Are Forecast
The forecast for transparency just turned cloudy. Key Messages Tucked into the latest opioid law are changes to the Sunshine Act. Beginning in 2022, drug and device companies now must report transfers...
View ArticleWhitelaw Compliance Group Presents at the 19th Annual Pharmaceutical &...
On Thursday, November 8th, Dr. Seth Whitelaw will be joining a distinguished panel of experts for an interactive discussion on the evolution of the compliance office from “Compliance 1.0 to 3.0”. The...
View ArticleSeason’s Greetings from Whitelaw Compliance Group
Click to view larger version The post Season’s Greetings from Whitelaw Compliance Group appeared first on Whitelaw Compliance Group, LLC.
View ArticleDecember 2018 Issue Now Available
Given that this is our last issue of 2018, we decided to focus on several important topics that never seem to get enough airtime. Therefore, we are featuring articles on privacy, including the new...
View ArticleMitchell Hamline Team Takes 2nd Place in Annual Health Law Regulatory and...
I am thrilled to share some great news! The 8th Annual Health Law Regulatory and Compliance Competition was held this past weekend at The University of Maryland Francis King Carey School of Law. This...
View ArticleThe Time for Effective Compliance Is NOW
Recently, the Justice Department targeted three companies in the pharmaceutical and medical device industry (Rochester Drug Co-Operative, Indivior, and Life Spine) as it aims to stamp out health care...
View ArticleLatest Issue of the Policy & Medicine Compliance Update
The post Latest Issue of the Policy & Medicine Compliance Update appeared first on Whitelaw Compliance Group, LLC.
View ArticlePharmaceutical & Medical Device Compliance Congress Turns 20
The post Pharmaceutical & Medical Device Compliance Congress Turns 20 appeared first on Whitelaw Compliance Group, LLC.
View ArticleThe Critical Need to Integrate Effective Compliance Controls in the Ongoing...
The post The Critical Need to Integrate Effective Compliance Controls in the Ongoing Opioid Settlements appeared first on Whitelaw Compliance Group, LLC.
View Article